fda compounding semaglutide crackdown news today 2025 How GLP-1 weight loss compounders reshaped the drug industry FDA GLP-1 Compounding Crackdown

You should consult your GP if you experience: Persistent difficulty managing blood glucose despite lifestyle modifications Unexplained weight gain or inability to lose weight despite sustained efforts Symptoms of diabetes (excessive thirst, frequent urination, unexplained fatigue) Family history of type 2 diabetes combined with other risk factors Important safety considerations : GLP-1 receptor agonists are prescription medications with potential adverse effects, most commonly gastrointestinal symptoms (nausea, vomiting, diarrhoea)

Others experience the opposite

There is no medical contraindication to starting GLP-1 therapy on any particular day

Retatrutide may become a staple of our obesity treatment arsenal

No in-office visit is required consultations, prescriptions when appropriate, and follow-ups are all handled online

[56] This activation reduces the production of reactive oxygen species (ROS) and mitigates endoplasmic reticulum (ER) stress